# Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)

> **NCT06454110** · PHASE2 · NOT_YET_RECRUITING · sponsor: **NovelMed Therapeutics** · enrollment: 10 (estimated)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** NM8074

## Key facts

- **NCT ID:** NCT06454110
- **Lead sponsor:** NovelMed Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2028-02
- **Primary completion:** 2030-12
- **Final completion:** 2031-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454110, "Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06454110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*